• Volkan İzol, Nebil Akdoğan, Haluk Özen, Bülent Akdoğan, Ali Rıza Kural, Mustafa Bilal Tuna, Sinan Sözen, Levent Türkeri, Mustafa Zühtü Tansuğ, and Members of Urooncology Association, Turkey.
• Department of Urology, Faculty of Medicine, Çukurova University, Adana, Turkey.
• Int. J. Clin. Pract. 2021 Aug 1; 75 (8): e14281.

PurposeTo evaluate the effect of risk factors and selected surgical methods on operative and oncological results of patients undergoing radical prostatectomy (RP) with high-risk prostate cancer (HRPC).MethodsRetrospective analysis of patients who underwent RP for HRPC from 13 urology centres between 1990 and 2019 was performed. Groups were created according to the risk factors of D'Amico classification. Patients with one risk factor were included in group 1 where group 2 consisted of patients with two or three risk factors.ResultsA total of 1519 patients were included in this study and 1073 (70.6%) patients were assigned to group 1 and 446 (29.4%) patients to group 2. Overall (biochemical and/or clinical and/or radiological) progression rate was 12.4% in group 1 and 26.5% in group 2 (P = .001). Surgical procedure was open RP in 844 (55.6%) patients and minimally invasive RP in 675 (44.4%) patients (laparoscopic and robot-assisted RP in 230 (15.1%) and 445 (29.3%) patients, respectively). Progression rates were similar in different types of operations (P = .22). Progression rate was not significantly different in patients who either underwent pelvic lymph node dissection (PLND) or not in each respective group.ConclusionRP alone is an effective treatment in the majority of patients with HRPC and PLND did not affect the progression rates after RP. According to the number of pre-operative high-risk features, as the number of risk factors increases, there is a need for additional treatment.© 2021 John Wiley & Sons Ltd.

16 keywords...

hide…